High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: a prospective cohort study
Authors:
- Roger I. CalderonRCRoger I. Calderon
- Maria B. ArriagaMaria B. Arriaga
- Kattya LopezKLKattya Lopez
- Nadia N. BarredaNBNadia N. Barreda
- Oswaldo M. SanabriaOSOswaldo M. Sanabria
- José F. Fróes NetoJNJosé F. Fróes Neto
- Davi Neri AraújoDADavi Neri Araújo
- Leonid LeccaLLLeonid Lecca
- Bruno B. AndradeBABruno B. Andrade
Open Access
- 11 September 2019
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 19 (1) , 1-11
Abstract
Background: The accuracy of different laboratory tests for diagnosis of diabetes mellitus (DM) and prediabetes (preDM) in populations exposed to tuberculosis (TB) remains poorly understood. Here, we examined the prevalence of DM and preDM in TB affected people in Lima, Peru. Methods: A prospective cohort study of patients affected TB and their household contacts (HHC), was conducted between February and November 2017 in Lima, Peru. Fasting plasma glucose (FPG), HbA1c and oral glucose tolerance test (OGTT) were used to detect DM and preDM in a prospective cohort of TB patients (n = 136) and household contacts (n = 138). Diagnostic performance of the laboratory tests was analyzed. Potential effects of sociodemographic and clinical factors on detection of dysglycemia were analyzed. Results: In TB patients, prevalence of DM and preDM was 13.97 and 30.88% respectively. Lower prevalence of both DM (6.52%) and preDM (28.99%) were observed in contacts. FPG, HbA1c and OGTT had poor agreement in detection of preDM in either TB cases or contacts. TB-DM patients had substantially lower hemoglobin levels, which resulted in low accuracy of HbA1c-based diagnosis. Classic sociodemographic and clinical characteristics were not different between TB patients with or without dysglycemia. Conclusion: High prevalence of DM and preDM was found in both TB patients and contacts in Lima. Anemia was strongly associated with TB-DM, which directly affected the diagnostic performance of HbA1c in such population.Keywords
Funding Information
- Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (CONCYTEC-Peru) / Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica (Convenio 175-2015)
This publication has 33 references indexed in Scilit:
- Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients—A study from IndiaDiabetes Research and Clinical Practice, 2013
- Global nutrition transition and the pandemic of obesity in developing countriesNutrition Reviews, 2012
- The impact of diabetes on tuberculosis treatment outcomes: A systematic reviewBMC Medicine, 2011
- A1C as a Diagnostic Criteria for Diabetes in Low- and Middle-Income Settings: Evidence from PeruPLOS ONE, 2011
- Implications of the global increase of diabetes for tuberculosis control and patient careTropical Medicine & International Health, 2010
- Utility of Glycated Hemoglobin in Diagnosing Type 2 Diabetes Mellitus: A Community-Based StudyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose toleranceActa Diabetologica, 2009
- Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TBEuropean Respiratory Journal, 2009
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational StudiesPLOS Medicine, 2008
- Low HbA1c levels in a poorly controlled diabeticPostgraduate Medical Journal, 2003